Ligand validation:4C9J

CDL: CARDIOLIPIN

CDL is a Ligand Of Interest in 4C9J designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4C9J_CDL_B_801	15%	35%	0.234	0.904	1.25	1.33	4	5	2	0	40%	0.4
4C9J_CDL_A_800	14%	38%	0.249	0.915	1.2	1.23	3	4	1	0	38%	0.38
4C9J_CDL_B_800	13%	48%	0.246	0.908	0.96	1.05	2	2	0	0	36%	0.36
4C9J_CDL_A_801	13%	37%	0.251	0.892	1.16	1.29	4	5	1	0	46%	0.46
4C9J_CDL_B_802	8%	25%	0.309	0.885	1.42	1.63	4	7	0	0	41%	0.41
4C9J_CDL_A_802	7%	29%	0.312	0.875	1.38	1.45	4	6	0	0	43%	0.43
4C9Q_CDL_B_802	17%	26%	0.22	0.906	1.48	1.53	4	5	3	0	39%	0.39
5Y5S_CDL_M_415	41%	34%	0.128	0.953	1.32	1.27	3	3	1	0	39%	0.39
2GNU_CDL_M_1309	38%	22%	0.122	0.984	1.77	1.5	3	3	0	0	10%	10
3ZDQ_CDL_A_1721	37%	64%	0.215	0.943	0.72	0.65	4	4	0	1	84%	0.42
6JY3_CDL_B_301	33%	24%	0.163	0.908	1.53	1.57	5	14	0	0	64%	0.64
7COH_CDL_A_521	33%	72%	0.212	0.901	0.46	0.6	-	2	6	0	94%	0.94

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.